RxDoctor Payments Data

Dagnex Jimenez Najarro, APRN

Family · Osceola, FLNPI 1578344008

Payments from drug & device makers

$932in general payments, 2019–2025

Across 53 payments — averaging $17.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$233
  • Phathom Pharmaceuticals, Inc.$107
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$101
  • Ironwood Pharmaceuticals, Inc$88
  • Intercept Pharmaceuticals, Inc.$77
  • Takeda Pharmaceuticals U.S.A., Inc.$59
  • plus $266 from 11 others

What the payments were for

  • Food & beverage$90097%
  • Education$323%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$932 in reported general payments places this provider in the 65th percentile of 14,618 family providers in Florida.

See all family providers in Florida

Medicare billing

Part B allowed, 2024
$6,480
Medicare patients
54
Services billed
70

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
LinzessLinaclotide37$38,121
Famotidine551$9,323
ClenpiqSod Picosulf/Mag Ox/Citric Ac45$7,546
Dicyclomine Hcl234$6,893
Dexlansoprazole DrDexlansoprazole11$4,955
Sucralfate160$3,758
Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates61$3,341
CholestyramineCholestyramine (With Sugar)17$2,632
Rabeprazole Sodium41$2,387
Ondansetron Hcl44$1,947
Esomeprazole Magnesium57$1,854
Peg 3350-ElectrolyteSodium Chloride/Nahco3/Kcl/Peg73$1,720
Lansoprazole45$1,578
Pantoprazole Sodium64$887
Hydrocortisone41$707

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieLinzess$233$38,12137 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 14,618 family providers in Florida.

Other family in Osceola

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →